| ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
| 297852 | P3P_LACLS | P15292; Q02VE4 | prtP | PIII-type proteinase; 3.4.21.96; Cell wall-associated serine proteinase; Lactocepin | 0 |
| 297851 | P3IP1_RAT | Q56A20 | Pik3ip1 | Phosphoinositide-3-kinase-interacting protein 1; Kringle domain-containing protein HGFL | 305472 |
| 297850 | P3IP1_PONAB | Q5RCS3 | PIK3IP1 | Phosphoinositide-3-kinase-interacting protein 1; Kringle domain-containing protein HGFL | 100172110 |
| 297849 | P3IP1_MOUSE | Q3TTD5; Q5NBY3; Q5NBY4; Q5NBY6; Q7TMJ8; Q811Z2; Q811Z3 | Pik3ip1 | Phosphoinositide-3-kinase-interacting protein 1; Calcineurin-regulated kringle domain-containing protein; Kringle domain-containing protein HGFL | 216505 |
| 297848 | P3IP1_HUMAN | B4DRR9; D1MEI0; O00318; Q49A94; Q86YW2; Q8NCJ9; Q96FE7 | PIK3IP1 | Phosphoinositide-3-kinase-interacting protein 1; PI3K-interacting protein 1; Kringle domain-containing protein HGFL | 113791 |
| 297847 | P3IP1_DANRE | Q7SXB3 | pik3ip1 | Phosphoinositide-3-kinase-interacting protein 1; Kringle domain-containing protein HGFL | 386643 |
| 297846 | P3IP1_BOVIN | Q1JPA4; Q1RMT9 | PIK3IP1 | Phosphoinositide-3-kinase-interacting protein 1; Kringle domain-containing protein HGFL | 512082 |
| 297845 | P3H3_MOUSE | O88836; Q8CG70 | P3h3 {ECO:0000312|MGI:MGI:1315208} | Prolyl 3-hydroxylase 3 {ECO:0000312|MGI:MGI:1315208}; 1.14.11.7; Leprecan-like protein 2 {ECO:0000303|PubMed:15063763}; Protein B {ECO:0000250|UniProtKB:Q8IVL6} | 14789 |
| 297844 | P3H3_HUMAN | Q13512; Q15740; Q66K32; Q6NX61; Q7L2T1; Q8IVL6 | P3H3 {ECO:0000312|HGNC:HGNC:19318} | Prolyl 3-hydroxylase 3 {ECO:0000312|HGNC:HGNC:19318}; 1.14.11.7; Leprecan-like protein 2 {ECO:0000303|PubMed:15063763}; Protein B {ECO:0000303|PubMed:8723724} | 10536 |
| 297843 | P3H2_STRSQ | O09345 | | L-proline cis-3-hydroxylase 2; P3H 2; 1.14.11.28; Proline 3-hydroxylase 2; Proline 3-hydroxylase type II | 0 |
| 297842 | P3H2_RAT | Q4KLM6 | P3h2 {ECO:0000312|RGD:1304568} | Prolyl 3-hydroxylase 2 {ECO:0000312|RGD:1304568}; 1.14.11.7 {ECO:0000305|PubMed:21757687}; Leprecan-like protein 1 {ECO:0000250|UniProtKB:Q8IVL5} | 288016 |
| 297841 | P3H2_MOUSE | Q8C673; Q8CG71 | P3h2 {ECO:0000312|MGI:MGI:2146663} | Prolyl 3-hydroxylase 2 {ECO:0000312|MGI:MGI:2146663}; 1.14.11.7 {ECO:0000305|PubMed:25645914}; Leprecan-like protein 1 {ECO:0000303|PubMed:15063763} | 210530 |
| 297840 | P3H2_HUMAN | B3KPK0; B3KWI9; D3DNV8; Q8IVL5; Q9NVI2 | P3H2 {ECO:0000312|HGNC:HGNC:19317} | Prolyl 3-hydroxylase 2 {ECO:0000312|HGNC:HGNC:19317}; 1.14.11.7 {ECO:0000269|PubMed:18487197}; Leprecan-like protein 1 {ECO:0000303|PubMed:15063763}; Myxoid liposarcoma-associated protein 4 {ECO:0000303|PubMed:10449603} | 55214 |
| 297839 | P3H2_CHICK | Q6JHU7 | P3H2 {ECO:0000250|UniProtKB:Q8IVL5} | Prolyl 3-hydroxylase 2 {ECO:0000250|UniProtKB:Q8IVL5}; 1.14.11.7 {ECO:0000250|UniProtKB:Q8IVL5}; Leprecan-like protein 1 {ECO:0000250|UniProtKB:Q8IVL5} | 414143 |
| 297838 | P3H1_STRSQ | P96010 | | L-proline cis-3-hydroxylase 1; P3H 1; 1.14.11.28; Proline 3-hydroxylase 1; Proline 3-hydroxylase type I | 0 |
| 297837 | P3H1_RAT | Q9R1J8 | P3h1 {ECO:0000312|RGD:628823} | Prolyl 3-hydroxylase 1 {ECO:0000312|RGD:628823}; 1.14.11.7; Leucine- and proline-enriched proteoglycan 1 {ECO:0000303|PubMed:10455179}; Leprecan-1 {ECO:0000303|PubMed:10455179} | 114200 |
| 297836 | P3H1_MOUSE | A2A7Q4; A6PW85; Q3TWX8; Q3V1T4; Q8BSV2; Q8CFL3; Q9CWK5; Q9QZT6; Q9QZT7 | P3h1 {ECO:0000312|MGI:MGI:1888921} | Prolyl 3-hydroxylase 1 {ECO:0000312|MGI:MGI:1888921}; 1.14.11.7; Growth suppressor 1 {ECO:0000303|PubMed:10951563}; Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8}; Leprecan-1 {ECO:0000250|UniProtKB:Q9R1J8} | 56401 |
| 297835 | P3H1_HUMAN | Q32P28; Q7KZR4; Q96BR8; Q96SK8; Q96SL5; Q96SN3; Q9H6K3; Q9HC86; Q9HC87 | P3H1 {ECO:0000312|HGNC:HGNC:19316} | Prolyl 3-hydroxylase 1 {ECO:0000312|HGNC:HGNC:19316}; 1.14.11.7; Growth suppressor 1 {ECO:0000303|PubMed:10951563}; Leucine- and proline-enriched proteoglycan 1 {ECO:0000250|UniProtKB:Q9R1J8}; Leprecan-1 {ECO:0000250|UniProtKB:Q9R1J8} | 64175 |
| 297834 | P3H1_CHICK | Q6JHU8 | P3H1 {ECO:0000250|UniProtKB:Q32P28} | Prolyl 3-hydroxylase 1 {ECO:0000250|UniProtKB:Q32P28}; 1.14.11.7 {ECO:0000269|PubMed:15044469}; Leucine- and proline-enriched proteoglycan 1 homolog {ECO:0000250|UniProtKB:Q9R1J8}; Leprecan-1 homolog {ECO:0000250|UniProtKB:Q9R1J8} | 414142 |
| 297833 | P3F4B_XENLA | Q6DJN3 | pou3f4-b | POU domain, class 3, transcription factor 4-B | 444776 |
| 297832 | P3F4A_XENLA | P31364; Q6DFJ0 | pou3f4-a | POU domain, class 3, transcription factor 4-A; Transcription factor POU2; XlPOU 2; XlPOU2 | 397929 |
| 297831 | P3F3B_DANRE | B3DJH8; P31366; P79744; P79745; Q6PHH6 | pou3f3b | POU domain, class 3, transcription factor 3-B; Brain-specific homeobox/POU domain protein 1.0; Brain-1.0; zfBrn-1.0; POU domain protein 1; ZFPOU1; POU domain protein 23; ZP-23 | 30321 |
| 297830 | P3F3A_DANRE | B0S7I5; B0S7I6; B0S7I7; B5DDP9; O57514; P56224; Q6IS23; Q6NZU9; Q6PE22 | pou3f3a | POU domain, class 3, transcription factor 3-A; Brain-specific homeobox/POU domain protein 1.1; Brain-1.1; zfBrn-1.1; Class III POU domain protein taichi; POU domain protein 12; ZP-12 | 30386 |
| 297829 | P3F2B_XENLA | B1H1P3; P70030; Q6IP58 | pou3f2-b | POU domain, class 3, transcription factor 2-B; Transcription factor POU3-B; XlPOU3B | 779122 |
| 297828 | P3F2A_XENLA | B7ZR71; P31365; Q8AVS5 | pou3f2-a | POU domain, class 3, transcription factor 2-A; Transcription factor POU3-A; XlPOU3A | 394422 |
| 297827 | P3F1B_XENLA | Q561L5 | pou3f1-b | POU domain, class 3, transcription factor 1-B; Homeotic protein NRL-34 {ECO:0000303|PubMed:2235499}; XlNRL-34; Homeotic protein NRL-34-A | 378582 |
| 297826 | P3F1A_XENLA | P20915; P31363; Q7ZYC6 | pou3f1-a | POU domain, class 3, transcription factor 1-A; Homeotic protein NRL-22; XlNRL-22; Transcription factor POU1; XlPOU 1; XlPOU1 | 394338 |
| 297825 | P3C2G_RAT | O70173 | Pik3c2g | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma {ECO:0000305|PubMed:9516481}; PI3K-C2-gamma; PtdIns-3-kinase C2 subunit gamma; 2.7.1.137 {ECO:0000269|PubMed:9516481}; 2.7.1.154 {ECO:0000269|PubMed:9516481}; Phosphoinositide 3-kinase-C2-gamma | 116720 |
| 297824 | P3C2G_MOUSE | O70167; O70168 | Pik3c2g | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma {ECO:0000305|PubMed:9514948}; PI3K-C2-gamma; PtdIns-3-kinase C2 subunit gamma; 2.7.1.137 {ECO:0000269|PubMed:9514948}; 2.7.1.154 {ECO:0000269|PubMed:9514948}; Phosphoinositide 3-kinase-C2-gamma | 18705 |
| 297823 | P3C2G_HUMAN | A1L3U0; O75747 | PIK3C2G | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma {ECO:0000305}; PI3K-C2-gamma; PtdIns-3-kinase C2 subunit gamma; 2.7.1.137 {ECO:0000250|UniProtKB:O70173}; 2.7.1.154 {ECO:0000250|UniProtKB:O70173}; Phosphoinositide 3-kinase-C2-gamma | 5288 |
| 297822 | P3C2B_HUMAN | O00750; O95666; Q5SW99 | PIK3C2B | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta; PI3K-C2-beta; PtdIns-3-kinase C2 subunit beta; 2.7.1.137 {ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11533253, ECO:0000269|PubMed:9830063}; 2.7.1.154 {ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:9830063}; C2-PI3K; Phosphoinositide 3-kinase-C2-beta | 5287 |
| 297821 | P3C2A_PONAB | Q5RAY1 | PIK3C2A | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha; PI3K-C2-alpha; PtdIns-3-kinase C2 subunit alpha; 2.7.1.137 {ECO:0000250|UniProtKB:O00443}; 2.7.1.153 {ECO:0000250|UniProtKB:O00443}; 2.7.1.154 {ECO:0000250|UniProtKB:O00443}; Phosphoinositide 3-kinase-C2-alpha | 100457125 |
| 297820 | P3C2A_MOUSE | Q61182; Q61194 | Pik3c2a | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha; PI3K-C2-alpha; PtdIns-3-kinase C2 subunit alpha; 2.7.1.137 {ECO:0000269|PubMed:10329640, ECO:0000269|PubMed:8663140}; 2.7.1.153 {ECO:0000250|UniProtKB:O00443}; 2.7.1.154 {ECO:0000250|UniProtKB:O00443}; Cpk-m; Phosphoinositide 3-kinase-C2-alpha; p170 | 18704 |
| 297819 | P3C2A_HUMAN | B0LPH2; B4E2G4; O00443; Q14CQ9 | PIK3C2A | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha; PI3K-C2-alpha; PtdIns-3-kinase C2 subunit alpha; 2.7.1.137 {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:9337861}; 2.7.1.153 {ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:9337861}; 2.7.1.154 {ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:9337861}; Phosphoinositide 3-kinase-C2-alpha | 5286 |
| 297818 | P3A_TYYVF | P0DJZ8 | ORF3a {ECO:0000305} | P3a; Protein ORF3a | 0 |
| 297817 | P3A_PLRV1 | P0DTK2 | ORF3a | Movement protein P3a {ECO:0000303|PubMed:30373157}; Protein ORF3a | 0 |
| 297816 | P3A2_STRPU | Q04073 | | DNA-binding protein P3A2 | 373404 |
| 297815 | P39_PCV87 | Q08316 | | Protein P39 | 991039 |
| 297814 | P37_MYCPN | P75371 | p37 | High affinity transport system protein p37 | 0 |
| 297813 | P37_MYCGE | Q49410 | p37 | High affinity transport system protein p37 | 0 |
| 297812 | P37_MESHY | P15363 | p37 | High affinity transport system protein p37 | 0 |
| 297811 | P35_NPVAC | P08160 | P35 | Early 35 kDa protein; Apoptosis-preventing protein; p35 | 1403968 |
| 297810 | P35_MALPE | P0DJ01; Q50367 | | Lipoprotein p35 | 0 |
| 297809 | P35_MALP2 | P0DJ00; Q50367 | | Lipoprotein p35 | 0 |
| 297808 | P358_HALSA | P84699 | | Protein VNG_0358C | 5953992 |
| 297807 | P34_SOYBN | P22895 | | P34 probable thiol protease; 3.4.22.- | 548062 |
| 297806 | P34_RICRS | A8GTY0; P21559 | p34 | Protein p34 | 45539758 |
| 297805 | P34_RICPR | Q9ZCC5 | p34 | Protein p34 | 57569955 |
| 297804 | P34_LIYV9 | Q83046 | | RNA-binding P34 protein; P34 | 0 |
| 297803 | P33_MALPE | P0DI99; Q50368 | | Lipoprotein p33 | 0 |
